Skip to main content

Want a detailed portfolio tracker?

SRRK
NASDAQ
$50.66

Scholar Rock Holding Corp (SRRK)

Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious diseases in which protein growth factor signaling plays a critical role. The company is headquartered in Cambridge, Massachusetts.
Website: https://www.scholarrock.com
Sector:
Healthcare
Industry:
Biotechnology
68 analysts
Buy
Target: $59.31 (+17.07%)

Market Cap

$6.44B

FCF 5Y CAGR

+26.01%

Free Cash Flow Yield

-4.72%

Beta (5Y)

0.67

Price Chart

Valuation
Market Cap$6.44B
P/S13.14
P/B23.35
Profitability
Gross Profit (TTM)-$212M
EBITDA-$408M
Profit Margin-23.9%
Operating Margin-20.9%
EPS-$3.90
Financial Health
Debt-to-Equity71.2%
Free Cash Flow Yield-4.72%
Growth & Risk
EPS 5Y CAGR+5.29%
FCF 5Y CAGR+26.01%
Beta (5Y)0.67
Sharpe Ratio0.51